In a 76‑year‑old man with metastatic prostate cancer on androgen‑deprivation therapy receiving low‑dose abiraterone 250 mg once daily, should prednisolone be given 5 mg once daily or 10 mg daily (5 mg twice daily)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisolone Dosing with Low-Dose Abiraterone 250 mg

When using low-dose abiraterone 250 mg once daily with food, prednisolone should be given at 5 mg twice daily (total 10 mg/day), not 5 mg once daily. 1, 2

Standard Glucocorticoid Requirement

  • The mandatory glucocorticoid dose remains prednisone 5 mg twice daily (or prednisolone 5 mg twice daily) regardless of whether you use standard-dose abiraterone 1,000 mg fasted or low-dose abiraterone 250 mg with food. 1, 2

  • The glucocorticoid requirement is driven by abiraterone's CYP17A1 inhibition, which causes mineralocorticoid excess (hypertension in ~22%, hypokalemia in ~17%, peripheral edema in ~28%), and this mechanism is independent of the abiraterone dose. 1, 2

  • Do not reduce prednisolone to 5 mg once daily—twice-daily dosing achieves ≥70% success in preventing mineralocorticoid excess, whereas once-daily dosing fails in the majority of patients. 2

Evidence for Low-Dose Abiraterone Regimen

  • The NCCN phase II noninferiority study that validated 250 mg abiraterone with a low-fat breakfast used the same prednisone dose of 5 mg twice daily as the standard 1,000 mg fasted regimen. 1

  • This low-dose approach (250 mg with food plus prednisone 5 mg twice daily) demonstrated noninferior PSA response (58% vs 50%) and equal progression-free survival (9 months in both arms) compared to standard dosing. 1

Critical Monitoring Requirements

  • Monthly monitoring during the first three months is mandatory, then at regular intervals, including: 2
    • Blood pressure (hypertension in ~22% of patients, severe in 4%) 2
    • Serum potassium (hypokalemia in ~17%) 2
    • Serum phosphate (hypophosphatemia in ~24%) 2
    • Liver enzymes (ALT/AST) (elevations leading to discontinuation in 11-12%) 2
    • Cardiac assessment for those with pre-existing cardiovascular disease (atrial fibrillation in 4%, cardiac disorders in 19%) 2

Important Clinical Caveats

  • The low-dose 250 mg regimen with food is Category 2B and should only be considered when patients cannot afford or will not take standard dosing; food impacts absorption unpredictably, requiring vigilant monitoring for excess toxicity. 1

  • If mineralocorticoid excess develops despite twice-daily prednisolone, add mineralocorticoid receptor antagonists (e.g., eplerenone) rather than discontinuing the glucocorticoid. 2

  • Standard dosing (1,000 mg fasted) should be resumed if excess toxicity is observed on the modified 250 mg with food regimen. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prednisone Dosing and Monitoring with Abiraterone in Prostate Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the absolute benefit of Androgen Deprivation Therapy (ADT) + Abiraterone (abiraterone) therapy in patients with metastatic hormone-sensitive prostate cancer?
Why is prednisone (steroid) given with abiraterone (Zytiga)?
What is the administration method for Abiraterone (Zytiga) in prostate cancer treatment?
What is the STAMPEDE (Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy) trial and its findings on the use of abiraterone (abiraterone acetate) plus prednisone in combination with androgen deprivation therapy (ADT) for men with high-risk or metastatic prostate cancer?
What is the recommended treatment regimen for castration-resistant prostate cancer using Abiraterone (abiraterone acetate)?
What does mild sacroiliac (SI) degenerative changes on a lumbar X‑ray indicate?
How should thymic squamous cell carcinoma be managed, including surgical resection, adjuvant radiotherapy and chemotherapy, and systemic therapy for unresectable or metastatic disease?
What are the three criteria of Whipple's triad used to confirm true hypoglycemia?
In a post‑renal‑transplant patient with reduced renal function, can ciprofloxacin (Cipro) and metronidazole (Metro) be used together for infection coverage, and what are the appropriate dose adjustments and monitoring for tacrolimus or cyclosporine levels?
In a post‑transplant patient with acute gastroenteritis, should ciprofloxacin and metronidazole be given empirically?
What are the current guidelines for managing acute upper and lower gastrointestinal bleeding in adults?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.